Stage III Nasopharyngeal Carcinoma AJCC v7
3 clinical trials · Condition
◉ Watch Stage III Nasopharyngeal Carcinoma AJCC v7
| Record | Firm | Date |
|---|---|---|
| Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors (NCT03074513) | M.D. Anderson Cancer Center | 2017-03-03 |
| Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer (NCT02339558) | National Cancer Institute (NCI) | 2015-07-21 |
| Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" (NCT01365169) | M.D. Anderson Cancer Center | 2011-05-25 |
Track Stage III Nasopharyngeal Carcinoma AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.